Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with remaining pathological tissue specimens removed during surgery from pancreatic cancer patients for whom surgery was indicated after heavy ion radiotherapy
Exclusion criteria
Exclusion criteria: Patients whose research subjects or their representatives have refused the use of pathological tissue specimens for this research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression pattern of target protein in pancreatic cancer specimens after heavy ion radiotherapy | — |
Countries
Japan
Contacts
National Institutes for Quantum Science and Technology Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science